Manuscripts

Search by keyword, year, or author name.

Showing 1530 manuscripts.

Results of the flow cytometry ACTG quality control program: analysis and findings

Helene M.A. Paxton, Pamela Gill Kidd, Alan Landay, Janis V. Giorgi, Neal Flomenberg, Edwin B. Walker, Fred T. Valentine, John L. Fahey, Rebecca S. Gelman. Results of the flow cytometry ACTG quality control program: analysis and findings. Clinical Immunology and Immunopathology (Now Clin Immunol). 1989. 52: 68-84.

Year

1989

Journal

Clinical Immunology and Immunopathology (Now Clin Immunol)

Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures

E. Sia, Janet Ailene Englund, Kim Sannerud, Karen Hansen, Nila Shah, Henry H. Balfour. Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures. Journal of Clinical Microbiology. 1989. 27: 1664-6.

Year

1989

Journal

Journal of Clinical Microbiology

Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus

Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. Morbidity and Mortality Weekly Report. 1989. 38: 1-9.

Year

1989

Journal

Morbidity and Mortality Weekly Report

Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone

Stephen A. Spector, D. Ripley, Karen Hsia. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone. Antimicrobial Agents and Chemotherapy. 1989. 33: 920-3.

Year

1989

Journal

Antimicrobial Agents and Chemotherapy

Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine

Mark A. Jacobson, Donald I. Abrams, Paul Volberding, P. Bacchetti, Judith C. Wilber, Richard E. Chaisson, S. M. Crowe, W. Howard, A. Moss. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. Journal of Infectious Diseases. 1989. 159: 1029-36.

Year

1989

Journal

Journal of Infectious Diseases

Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs

Richard A. Koup, John L. Sullivan, Peter H. Levine, Doreen Barbara Brettler, Anna Mahr, Gail Mazzara, Sara J. McKenzie, Dennis Panicali. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood. 1989. 73: 1909-14.

Year

1989

Journal

Blood

Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages

David J. Eilbott, Nancy Peress, Harold Burger, Debra La Neve, Jan Orenstein, Howard E. Gendelman, Roberta Seidman, Barbara Weiser. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proceedings of the National Academy of Sciences of the United States of America. 1989. 86: 3337-41.

Year

1989

Journal

Proceedings of the National Academy of Sciences of the United States of America

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

Mark A. Jacobson, James O'Donnell, John Mills. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrobial Agents and Chemotherapy. 1989. 33: 736-41.

Year

1989

Journal

Antimicrobial Agents and Chemotherapy

Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis

Francesca Aweeka, John G. Gambertoglio, John Mills, Mark A. Jacobson. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrobial Agents and Chemotherapy. 1989. 33: 742-5.

Year

1989

Journal

Antimicrobial Agents and Chemotherapy

The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker

Stephen A. Spector, C. Kennedy, J. Allen McCutchan, Sam Bozzette, R. G. Straube, James D. Connor, Douglas D. Richman. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. Journal of Infectious Diseases. 1989. 159: 822-8.

Year

1989

Journal

Journal of Infectious Diseases